Literature DB >> 28340228

Dual Immunostain With SATB2 and CK20 Differentiates Appendiceal Mucinous Neoplasms From Ovarian Mucinous Neoplasms.

Zaibo Li1, Rachel Roth1, Jonathan B Rock1, Amy Lehman2, William L Marsh1, Adrian Suarez1, Wendy L Frankel1.   

Abstract

OBJECTIVES: Determination of the primary site of origin for mucinous neoplasms identified in the peritoneal and/or pelvic cavities may be challenging, with major differential diagnoses including appendiceal mucinous neoplasm (AMN) and ovarian mucinous neoplasm (OMN). Special AT-rich sequence binding protein 2 (SATB2) has been shown to be highly selectively expressed in the lower gastrointestinal tract, including the appendix.
METHODS: We investigated the utility of a dual stain (DS) with SATB2 or caudal type homeobox 2 (CDX2) and cytokeratin 20 (CK20) or villin in distinguishing AMNs from OMNs. Tissue microarrays with 40 AMNs and 18 OMNs were stained with SATB2 or CDX2 paired with either CK20 or villin.
RESULTS: SATB2 single stain showed a good sensitivity of 83% and the highest specificity of 78% for AMNs over OMNs among all four stains. DS with SATB2 and villin showed an identical sensitivity of 78% but specificity increased to 94%, while DS with SATB2 and CK20 showed a sensitivity of 80% and a specificity of 100%. In contrast, DS with CDX2 and CK20/villin showed slightly higher sensitivity but much lower specificity.
CONCLUSIONS: DS with SATB2/CK20 shows the greatest potential clinical utility in distinguishing AMNs from OMNs and is superior to DS with CDX2/CK20. Importantly, DS could be helpful for specimens with limited tissues. © American Society for Clinical Pathology, 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Appendiceal mucinous neoplasm; CDX2; CK20; Dual immunostain; Ovarian mucinous neoplasm; SATB2; Villin

Mesh:

Substances:

Year:  2017        PMID: 28340228      PMCID: PMC6248525          DOI: 10.1093/ajcp/aqx023

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  35 in total

1.  Small cell osteosarcoma: clinicopathologic, immunohistochemical, and molecular analysis of 36 cases.

Authors:  Alberto Righi; Marco Gambarotti; Serena Longo; Stefania Benini; Gabriella Gamberi; Stefania Cocchi; Daniel Vanel; Piero Picci; Franco Bertoni; Antonella Simoni; Alessandro Franchi; Angelo Paolo Dei Tos
Journal:  Am J Surg Pathol       Date:  2015-05       Impact factor: 6.394

2.  Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases.

Authors:  Peiguo G Chu; Lawrence Chung; Lawrence M Weiss; Sean K Lau
Journal:  Am J Surg Pathol       Date:  2011-12       Impact factor: 6.394

3.  Improved confidence intervals for the difference between binomial proportions based on paired data.

Authors:  R G Newcombe
Journal:  Stat Med       Date:  1998-11-30       Impact factor: 2.373

4.  CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall.

Authors:  Robert M Mazziotta; Alain C Borczuk; Charles A Powell; Mahesh Mansukhani
Journal:  Appl Immunohistochem Mol Morphol       Date:  2005-03

5.  Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.

Authors:  Russell Vang; Allen M Gown; Lee-Shu-Fune Wu; Todd S Barry; Darren T Wheeler; Anna Yemelyanova; Jeffrey D Seidman; Brigitte M Ronnett
Journal:  Mod Pathol       Date:  2006-09-15       Impact factor: 7.842

6.  A comprehensive analysis of PAX8 expression in human epithelial tumors.

Authors:  Anna R Laury; Ruth Perets; Huiying Piao; Jeffrey F Krane; Justine A Barletta; Christopher French; Lucian R Chirieac; Rosina Lis; Massimo Loda; Jason L Hornick; Ronny Drapkin; Michelle S Hirsch
Journal:  Am J Surg Pathol       Date:  2011-06       Impact factor: 6.394

7.  Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma.

Authors:  Sanjay Logani; Esther Oliva; Paula M Arnell; Mahul B Amin; Robert H Young
Journal:  Mod Pathol       Date:  2005-01       Impact factor: 7.842

8.  SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.

Authors:  James R Conner; Jason L Hornick
Journal:  Histopathology       Date:  2013-05-23       Impact factor: 5.087

9.  Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer.

Authors:  Shuang Wang; Jun Zhou; Xiao-Yan Wang; Jun-Mei Hao; Juan-Zhi Chen; Xiang-Mei Zhang; He Jin; Li Liu; Yan-Fei Zhang; Jinsong Liu; Yan-Qing Ding; Jian-Ming Li
Journal:  J Pathol       Date:  2009-09       Impact factor: 7.996

10.  CDX-2 immunostaining in primary and secondary ovarian carcinomas.

Authors:  L Tornillo; H Moch; P-A Diener; A Lugli; G Singer
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

View more
  4 in total

1.  SATB2 Shows Different Profiles Between Appendiceal Adenocarcinomas Ex Goblet Cell Carcinoids and Appendiceal/Colorectal Conventional Adenocarcinomas: An Immunohistochemical Study With Comparison to CDX2.

Authors:  Chen Yang; Li Sun; Lingxin Zhang; Lixin Zhou; Dongfeng Niu; Wenfeng Cao; Zhongwu Li; Xiaozheng Huang; Qiang Kang; Lin Jia; Marina Platik; Xiuli Liu; Jinping Lai; Dengfeng Cao
Journal:  Gastroenterology Res       Date:  2018-05-31

Review 2.  Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics.

Authors:  Pavel Dundr; Naveena Singh; Barbora Nožičková; Kristýna Němejcová; Michaela Bártů; Ivana Stružinská
Journal:  Diagn Pathol       Date:  2021-03-11       Impact factor: 2.644

Review 3.  Breast Metastasis From Rectal Signet-Ring Cell Carcinoma: A Case Report and Review of Literature.

Authors:  Yuran Dai; Yudi Jin; Ailin Lan; Nan Ding; Linshan Jiang; Shengchun Liu
Journal:  Front Oncol       Date:  2022-04-04       Impact factor: 5.738

4.  Dual Stain With SATB2 and CK20/Villin Is Useful to Distinguish Colorectal Carcinomas From Other Tumors.

Authors:  Zaibo Li; Jonathan B Rock; Rachel Roth; Amy Lehman; William L Marsh; Adrian Suarez; Wendy L Frankel
Journal:  Am J Clin Pathol       Date:  2018-02-17       Impact factor: 2.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.